Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening.
about
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsortiumA Practical Approach to Newborn Screening for Severe Combined Immunodeficiency Using the T Cell Receptor Excision Circle Assay.
P2860
Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Treatment of infants identifie ...... by means of newborn screening.
@en
type
label
Treatment of infants identifie ...... by means of newborn screening.
@en
prefLabel
Treatment of infants identifie ...... by means of newborn screening.
@en
P2093
P2860
P1476
Treatment of infants identifie ...... by means of newborn screening.
@en
P2093
Christopher C Dvorak
Jennifer M Puck
Morna J Dorsey
Morton J Cowan
P2860
P304
P356
10.1016/J.JACI.2017.01.005
P407
P577
2017-03-01T00:00:00Z